Sujal Shah, Chief Financial Officer at CymaBay Therapeutics, Inc. (CBAY), bought 55,000 shares at $1.39 ($76K) on 2016-04-04, disclosed to the SEC on 2016-04-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.39 | 22,000 | $31K | 40.0% |
| 2 | $1.39 | 33,000 | $46K | 60.0% |
| Total | $1.39 avg | 55,000 | $76K | 100% |
| Filing → |
| CBAY | SELL | 2023-10-10 | $1.8M | — | Filing → |
| CBAY | BUY | 2022-06-07 | $200K | — | Filing → |
| CBAY | BUY | 2019-10-15 | $22K | — | Filing → |